Suppr超能文献

一种与4F2hc相关联以编码氨基酸转运活性y + L的膜蛋白(y + L氨基酸转运体-1)的鉴定与表征。赖氨酸尿性蛋白不耐受的一个候选基因。

Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance.

作者信息

Torrents D, Estévez R, Pineda M, Fernández E, Lloberas J, Shi Y B, Zorzano A, Palacín M

机构信息

Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Avda. Diagonal 645, 08028 Barcelona, Spain.

出版信息

J Biol Chem. 1998 Dec 4;273(49):32437-45. doi: 10.1074/jbc.273.49.32437.

Abstract

We have identified a new human cDNA (y+L amino acid transporter-1 (y+LAT-1)) that induces system y+L transport activity with 4F2hc (the surface antigen 4F2 heavy chain) in oocytes. Human y+LAT-1 is a new member of a family of polytopic transmembrane proteins that are homologous to the yeast high affinity methionine permease MUP1. Other members of this family, the Xenopus laevis IU12 and the human KIAA0245 cDNAs, also co-express amino acid transport activity with 4F2hc in oocytes, with characteristics that are compatible with those of systems L and y+L, respectively. y+LAT-1 protein forms a approximately 135-kDa, disulfide bond-dependent heterodimer with 4F2hc in oocytes, which upon reduction results in two protein bands of approximately 85 kDa (i.e. 4F2hc) and approximately 40 kDa (y+LAT-1). Mutation of the human 4F2hc residue cysteine 109 (Cys-109) to serine abolishes the formation of this heterodimer and drastically reduces the co-expressed transport activity. These data suggest that y+LAT-1 and other members of this family are different 4F2 light chain subunits, which associated with 4F2hc, constitute different amino acid transporters. Human y+LAT-1 mRNA is expressed in kidney >> peripheral blood leukocytes >> lung > placenta = spleen > small intestine. The human y+LAT-1 gene localizes at chromosome 14q11.2 (17cR approximately 374 kb from D14S1350), within the lysinuric protein intolerance (LPI) locus (Lauteala, T., Sistonen, P. , Savontaus, M. L., Mykkanen, J., Simell, J., Lukkarinen, M., Simmell, O., and Aula, P. (1997) Am. J. Hum. Genet. 60, 1479-1486). LPI is an inherited autosomal disease characterized by a defective dibasic amino acid transport in kidney, intestine, and other tissues. The pattern of expression of human y+LAT-1, its co-expressed transport activity with 4F2hc, and its chromosomal location within the LPI locus, suggest y+LAT-1 as a candidate gene for LPI.

摘要

我们鉴定出一种新的人类cDNA(y⁺L氨基酸转运体-1(y⁺LAT-1)),它能在卵母细胞中与4F2hc(表面抗原4F2重链)共同诱导系统y⁺L的转运活性。人类y⁺LAT-1是多跨膜蛋白家族的新成员,与酵母高亲和力甲硫氨酸通透酶MUP1同源。该家族的其他成员,即非洲爪蟾IU12和人类KIAA0245 cDNA,也能在卵母细胞中与4F2hc共同表达氨基酸转运活性,其特征分别与系统L和y⁺L的特征相符。y⁺LAT-1蛋白在卵母细胞中与4F2hc形成一个约135 kDa的、依赖二硫键的异二聚体,还原后会产生两条蛋白带,分别约为85 kDa(即4F2hc)和约40 kDa(y⁺LAT-1)。将人类4F2hc残基半胱氨酸109(Cys-109)突变为丝氨酸会消除这种异二聚体的形成,并大幅降低共同表达的转运活性。这些数据表明,y⁺LAT-1和该家族的其他成员是不同的4F2轻链亚基,它们与4F2hc结合,构成不同的氨基酸转运体。人类y⁺LAT-1 mRNA在肾脏中的表达量 >> 外周血白细胞 >> 肺 > 胎盘 = 脾脏 > 小肠。人类y⁺LAT-1基因定位于染色体14q11.2(距D14S1350约17cR,约374 kb),位于赖氨酸尿蛋白不耐受(LPI)基因座内(劳特拉,T.,西斯托宁,P.,萨翁陶斯,M.L.,米卡宁,J.,西梅尔,J.,卢卡里宁,M.,西梅尔,O.,和奥拉,P.(1997年)《美国人类遗传学杂志》60,1479 - 1486)。LPI是一种遗传性常染色体疾病,其特征是肾脏、肠道和其他组织中的二碱基氨基酸转运存在缺陷。人类y⁺LAT-1的表达模式、其与4F2hc共同表达的转运活性以及它在LPI基因座内的染色体定位,表明y⁺LAT-1是LPI的候选基因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验